Ethical issues in medical cannabis use

Area of Science:

• Medical Ethics
• Pharmacology
• Public Health Policy

Background:

• The widespread adoption of medical cannabis (MC) necessitates a thorough examination of its ethical landscape.
• Current regulatory frameworks for MC vary significantly across jurisdictions, creating inconsistencies in access and oversight.
• Physicians face knowledge gaps regarding MC characteristics and navigate complex interactions involving patients and commercial entities.

Purpose of the Study:

• To delineate the multifaceted ethical considerations surrounding medical cannabis use for clinicians.
• To analyze the regulatory, professional, and medical/psychological implications of MC prescribing.
• To contextualize these issues within the evolving policy environment of cannabis legalization.

Main Methods:

• Literature review of ethical guidelines and regulatory policies pertaining to medical cannabis.
• Analysis of professional practice standards and knowledge gaps among healthcare providers.
• Discussion of medical and psychological implications based on current research.

Main Results:

• Significant ethical dilemmas arise from regulatory inconsistencies and a lack of standardized MC certification.
• Professional challenges include insufficient clinician knowledge of MC and potential conflicts of interest.
• Medical and psychological implications require careful patient assessment and management.

Conclusions:

• The rapid shift towards cannabis legalization creates a dynamic environment requiring clinicians to address complex ethical, regulatory, and clinical challenges.
• Enhanced education and clear guidelines are essential for healthcare professionals navigating medical cannabis prescribing.
• A balanced approach is needed to ensure patient safety and ethical practice amidst evolving cannabis policies.